8chan/8kun QResearch Posts (9)
#13851890 at 2021-06-07 21:26:46 (UTC+1)
Q Research General #17535: Remember Remember The Great Pandemic of Fauci, Covid And Shots Edition
>>13851436
>September 13, 2018
Throwing out some URL that contain that date (via qresear.ch);
Forged voter signatures could cost former state Senate candidate Mark Syms $50,000
https://www.azcentral.com/story/news/politics/elections/2018/09/13/judge-arizona-candidate-mark-syms-owes-50-000-forged-signatures/1279908002/
https://nypost.com/2018/09/13/this-nyc-priests-dramatic-downfall-was-just-the-beginning-of-perv-priest-scandals/
https://www.detroitnews.com/story/news/local/michigan/2018/09/13/gov-snyder-traveling-china-amid-trade-war/1291223002/
https://foreignpolicy.com/2018/09/13/the-oslo-accords-are-dead-but-there-is-still-a-path-to-peace-israeli-palestinian-arafat-rabin-clinton/
https://www.thenewsstar.com/story/news/2018/09/13/its-gusher-u-s-takes-global-oil-lead-but-la-lags/1288764002/
https://www.nytimes.com/2018/09/13/nyregion/letitia-james-attorney-general.html
https://theconservativetreehouse.com/2018/09/13/barely-coherent-supreme-court-justice-ruth-bader-ginsburg-makes-an-appearance/
https://www.nytimes.com/2018/09/13/health/Jose-Baselga-cancer-memorial-sloan-kettering.html
https://www.marinecorpstimes.com/news/your-military/2018/09/13/the-marine-corps-is-quietly-monitoring-sections-of-the-us-mexico-border-to-stop-migrants-and-drug-traffickers/
https://www.npr.org/2018/09/13/647621382/multiple-explosions-and-fires-reported-across-3-massachusetts-towns-at-least-3-i
https://www.dhs.gov/news/2018/09/13/secretary-nielsen-statement-president-trump-s-election-security-executive-order
https://www.nytimes.com/2018/09/13/opinion/michael-avenatti-trump-indictment-stormy-daniels.html
#13280343 at 2021-03-23 08:30:46 (UTC+1)
Q Research General #16823: The '[They] Want You Divided By [insert topic here]' Edition
>>13280234
Coincidence?
March 21, 2021
José Baselga, renowned cancer researcher and AstraZeneca oncology R&D head, dies at 61
José Baselga, a storied oncology researcher and pharmaceutical executive whose discoveries helped pave the way for new breast cancer therapies, died Sunday at the age of 61.
His death was confirmed by AstraZeneca, where Baselga had been serving as executive vice president for research and development in oncology. The company did not provide a cause of death; the Spanish newspaper La Vanguardia reported it was Creutzfeldt-Jakob disease, a rare brain infection that causes degeneration and death.
Baselga had joined AstraZeneca two years ago, after his academic career ended amid a conflict-of-interest scandal at Memorial Sloan Kettering Cancer Center.
"An outstanding scientific leader, José leaves a lasting legacy in the scientific community and here at AstraZeneca," company CEO Pascal Soriot said in a statement. Soriot added of Baselga, "His visionary leadership, deep scientific expertise and strategic insight have delivered so many achievements that we can all be proud of and that will benefit patients' lives in the years to come."
Anas Younes, who worked with Baselga in academia and at AstraZeneca and had known him since 1986, told STAT that Baselga was "ambitious, resilient, caring, brilliant - and joyful."
"People don't understand that - he was a really funny person to be around," Younes said.
Baselga had both an M.D. and Ph.D., and his academic career included stops at Vall d'Hebron University Hospital in his native Spain, Massachusetts General Hospital, and Memorial Sloan Kettering, where he was ultimately chief medical officer and physician-in-chief.
During his career, Baselga was involved in the clinical development of multiple cancer therapies, including trastuzumab (also known as Herceptin), according to a biography from the American Association for Cancer Research. His scientific pursuits focused on finding therapeutic agents based on genetic mutations and molecular targets on tumors, and on investigating how cancers became resistant to treatment.
Baselga was best known as a breast cancer researcher, but in his leadership at MSKCC, he shaped scientific strategies across disease types, Younes said.
During his academic career, Baselga collaborated with and served as an adviser to startups as well as major pharmaceutical companies, which is common for investigators working on taking potential treatments from research labs into patients.
But in 2018, ProPublica and the New York Times reported that Baselga had failed to disclose receiving millions of dollars from drug and other health care companies in research articles he published in academic journals. Baselga told the news organizations the omissions had been unintentional.
Baselga resigned from MSKCC soon after, and in January 2019, joined AstraZeneca as the drug maker shifted more of its focus to cancer.
He is survived by his wife, Silvia, and four children.
"José was more than a colleague to me," Soriot's statement said. "He was a friend, and someone I immensely respected and cherished. I will enormously miss having him alongside me, and I will continue to be inspired by his work and vision."
https://www.statnews.com/2021/03/21/Jose-Baselga-astrazeneca-renowned-cancer-researcher-dies-at-61/
#5689121 at 2019-03-15 00:41:17 (UTC+1)
Q Research General #7275: Stand strong, Patriots Edition
>>5688830
The Lies Behind Justice Ginsburg's "Cancer Free" Diagnosis
01/16/2019
In reports that circulated several days ago regarding the health status of Supreme Court Justice Ruth Bader Ginsburg, one is expected to believe the veracity of the information put forth by the media outlets who disseminated this highly questionable report. According to reports, on January 11th, Supreme Court spokesperson Kathleen Arberg addressed the lung cancer surgery that Justice Ginsburg recently underwent. Arberg announced that Justice Ginsburg had "beaten cancer once again after surgery for two malignant lymph nodes last month. Her recovery from surgery is on track." She added that "post-surgery evaluation indicates no evidence of remaining disease, and no further treatment in required." After falling and breaking three ribs, Justice Ginsburg's doctors discovered cancerous nodes in her lungs.
In reports that circulated several days ago regarding the health status of Supreme Court Justice Ruth Bader Ginsburg, one is expected to believe the veracity of the information put forth by the media outlets who disseminated this highly questionable report. Photo Credit: Shutterstock
Isn't that interesting? Just fresh out of surgery without the pathology reports available from reputable doctors and such an unsubstantiated diagnosis has been made?
Yes, Judge Ginsburg has beaten cancer in the past, but a cancer determination does not just disappear. Rather it goes into remission; if one is fortunate enough. Thus far, no doctors who treated Justice Ginsburg have corroborated this statement and the simple reason for that is that it is medically untenable and highly irresponsible for any physician to make such an unverified statement at this time.
Seems like political bias has infected this story as well. For liberal Democrats, Ginsburg is the person on the bench that they have pinned their last remaining hope to. Having her vacate her seat on the court at this juncture in time would be tantamount to a whirling dervish of a nightmare for them. So, in order to cool the jets of the overly anxious GOP, (who, the Dems erroneously believe are already beginning a vetting and selection process for Ginsburg's replacement), they are telling the world to rest assured that Justice Ginsburg will be back in court just as soon as possible.
Politics has no limit on the extent to which hyperbole or alternative facts will be used.
On another entirely separate matter, in order to gain clarity, one must cast a vigilant eye on the medical establishment and those physicians who were treating Justice Ginsburg. Yet another disturbing angle to this story has emerged.
For those who are of the belief that the doctors who attended to Justice Ginsburg at NYC's Memorial Sloan Kettering Hospital have confirmed that she is cancer free yet have remained silent due to patient privacy laws, let's take another look.
Just who are these doctors at Sloan Kettering? Several months ago a chief oncologist at Sloan named Dr. Jose Baselga, resigned in disgrace after it was revealed that he was taking huge monetary kick backs from mega pharmaceutical companies. It was recently announced that Dr. Baselga (now out of a job at Sloan) is currently in the employ of AstraZeneca, the Swiss based drug company.
In the dozens of articles that Dr. Baselga penned for such prestigious publications as The New England Journal of Medicine and The Lancet, he had omitted that he was accepting payments from various drug and health care companies.
Dr. Baselga came to Memorial Sloan Kettering in 2013 after serving as chief of hematology and oncology at Massachusetts General Hospital in Boston. Before that he was a leader at the Vall d'Hebron Institute of Oncology in Barcelona, Spain.
Moreover, Dr. Baselga has served in an advisory capacity with such pharmaceutical companies at Roche and Bristol-Myers Squibb, among other drug companies. Dr. Baselga also resigned from the board of Bristol-Myers Squibb, which he had served on since March of 2018.
Since 2014, Dr. Baselga has received $3 million in consulting fees from Roche.
The egregious findings really rocked Sloan Kettering to the core. The hospital's leading executives made a feverish effort to tamp down the negative impact of such revelations on the institution's reputation for medical excellence.
Well, this distressing news compels us to shine some sunlight on the state of affairs of our medical profession. We must take stock and ask ourselves, "how many other doctors who manage and ostensibly treat patients with life threatening illnesses are also on the payroll of Big Pharma? How many doctors that we trust are in reality just executing the agenda of their handlers when dispensing meds to patients?"
http://thejewishvoice.com/2019/01/16/the-lies-behind-justice-ginsburgs-cancer-free-diagnosis/
#5194098 at 2019-02-15 20:27:37 (UTC+1)
Q Research General #6636: The Pace Quickens Edition
RGB is/was being treated a Sloan Kettering Memorial hospital. Recent news stories feature corrupt administrators for Big Pharma off book.
https://www.nytimes.com/2018/09/13/health/Jose-Baselga-cancer-memorial-sloan-kettering.html
https://www.beckershospitalreview.com/hospital-management-administration/memorial-sloan-kettering-scandal-prompts-wave-of-medical-journal-corrections-from-top-facilities.html
https://www.dailykos.com/stories/2018/12/21/1820823/-Justice-Ruth-Bader-Ginsburg-Just-Had-Cancer-Surgery-Speedy-Recovery-RGB
#5004664 at 2019-02-02 20:39:58 (UTC+1)
Q Research General #6390: The Shaggy Defense Edition
>>5004656
Bread 5944
>>4658875
Top Cancer Doctor, Forced Out Over Ties to Drug Makers, Joins Their Ranks
AstraZeneca has hired Dr. José Baselga, the former chief medical officer at Memorial Sloan Kettering, to lead its cancer research unit.
www.propublica.org/article/astrazeneca-hires-dr-Jose-Baselga/amp
#4658875 at 2019-01-08 08:01:43 (UTC+1)
Q Research General #5944: Happy Birthday Qs 1st Board, GreatAwakening Edition
>>4658442
[RBG]
Supreme Court Justice Ruth Bader Ginsburg released from hospital after cancer surgery
www.usatoday.com/story/news/politics/2018/12/26/ruth-bader-ginsburg-supreme-court-justice-released-hospital/2413300002/
and
Top Cancer Doctor, Forced Out Over Ties to Drug Makers, Joins Their Ranks
AstraZeneca has hired Dr. José Baselga, the former chief medical officer at Memorial Sloan Kettering, to lead its cancer research unit.
www.propublica.org/article/astrazeneca-hires-dr-Jose-Baselga/amp
#4627799 at 2019-01-06 17:49:53 (UTC+1)
Q Research General #5904: Eye for an Eye, USS Cole Payback Edition
RBG had cancer treatment at Sloan Kettering Hospital in NYC
https://www.dailywire.com/news/39602/ruth-bader-ginsburg-undergoes-surgery-lung-cancer-paul-bois
Same institution's chief medical officer resigned after taking millions from big pharma.
https://www.propublica.org/article/memorial-sloan-kettering-official-Jose-Baselga-resigns-after-failing-to-disclose-industry-ties
Related to - What 'off-market' drugs are being provided to [RBG] in order to sustain minimum daily function?
#3171887 at 2018-09-25 00:37:40 (UTC+1)
Q Research General #4015: Christine Ford Was Passed Around, But Not By Judge K Edition
Three prominent US scientists have been pushed to resign over the past 10 days
The most spectacular fall concerned Jose Baselga, chief medical officer at Memorial Sloan Kettering Cancer Center in New York. He authored hundreds of articles on cancer research.
Baselga failed to disclose in dozens of research articles that he had received millions of dollars from pharmaceutical and medical companies.
Next came the case of Brian Wansink, director of the Food and Brand Lab at the prestigious Cornell University.
He made his name thanks to studies that garnered plenty of media attention, including on pizza, and the appetites of children.
In the final case, Gilbert Welch, a professor of public health at Dartmouth College, resigned last week.
The university accused him of plagiarism in an article published in The New England Journal of Medicine, the most respected American medical journal.
https://www.yahoo.com/news/fall-top-us-scientists-points-ethics-gap-research-045350389.html
#3169616 at 2018-09-24 21:35:40 (UTC+1)
Q Research General #4012: DECLAS Of FISA = [RR] Self-Incrimination Edition
This is why they keep pushing the lie of global warming nobody gets fired for lying
Corrupt Scientists Driven To Resign, but Not Climate Scientists?
Three prominent US scientists have been pushed to resign over the past 10 days after damning revelations about their methods, a sign of greater vigilance and decreasing tolerance for misconduct within the research community.
The most spectacular fall concerned Jose Baselga, chief medical officer at Memorial Sloan Kettering Cancer Center in New York. He authored hundreds of articles on cancer research.
https://www.technocracy.news/corrupt-scientists-driven-to-resign-but-not-climate-scientists/
8kun Midnight Riders Posts (1)
#72610 at 2021-03-23 08:16:47 (UTC+1)
QR Midnight Riders #325: Target Aquired, Direct Hit! Edition
>>72609
Coincidence?
March 21, 2021
José Baselga, renowned cancer researcher and AstraZeneca oncology R&D head, dies at 61
José Baselga, a storied oncology researcher and pharmaceutical executive whose discoveries helped pave the way for new breast cancer therapies, died Sunday at the age of 61.
His death was confirmed by AstraZeneca, where Baselga had been serving as executive vice president for research and development in oncology. The company did not provide a cause of death; the Spanish newspaper La Vanguardia reported it was Creutzfeldt-Jakob disease, a rare brain infection that causes degeneration and death.
Baselga had joined AstraZeneca two years ago, after his academic career ended amid a conflict-of-interest scandal at Memorial Sloan Kettering Cancer Center.
"An outstanding scientific leader, José leaves a lasting legacy in the scientific community and here at AstraZeneca," company CEO Pascal Soriot said in a statement. Soriot added of Baselga, "His visionary leadership, deep scientific expertise and strategic insight have delivered so many achievements that we can all be proud of and that will benefit patients' lives in the years to come."
Anas Younes, who worked with Baselga in academia and at AstraZeneca and had known him since 1986, told STAT that Baselga was "ambitious, resilient, caring, brilliant - and joyful."
"People don't understand that - he was a really funny person to be around," Younes said.
Baselga had both an M.D. and Ph.D., and his academic career included stops at Vall d'Hebron University Hospital in his native Spain, Massachusetts General Hospital, and Memorial Sloan Kettering, where he was ultimately chief medical officer and physician-in-chief.
During his career, Baselga was involved in the clinical development of multiple cancer therapies, including trastuzumab (also known as Herceptin), according to a biography from the American Association for Cancer Research. His scientific pursuits focused on finding therapeutic agents based on genetic mutations and molecular targets on tumors, and on investigating how cancers became resistant to treatment.
Baselga was best known as a breast cancer researcher, but in his leadership at MSKCC, he shaped scientific strategies across disease types, Younes said.
During his academic career, Baselga collaborated with and served as an adviser to startups as well as major pharmaceutical companies, which is common for investigators working on taking potential treatments from research labs into patients.
But in 2018, ProPublica and the New York Times reported that Baselga had failed to disclose receiving millions of dollars from drug and other health care companies in research articles he published in academic journals. Baselga told the news organizations the omissions had been unintentional.
Baselga resigned from MSKCC soon after, and in January 2019, joined AstraZeneca as the drug maker shifted more of its focus to cancer.
He is survived by his wife, Silvia, and four children.
"José was more than a colleague to me," Soriot's statement said. "He was a friend, and someone I immensely respected and cherished. I will enormously miss having him alongside me, and I will continue to be inspired by his work and vision."
https://www.statnews.com/2021/03/21/Jose-Baselga-astrazeneca-renowned-cancer-researcher-dies-at-61/